Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 21)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
FDA Approves Bydureon - The First and Only Once-Weekly Treatment for Type 2 Diabetes
SAN DIEGO and DUBLIN, Jan. 27, 2012 /PRNewswire/ – Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has approved Bydureon (exenatide...
FDA Approves Combination Therapy Juvisync
SILVER SPRING, Md., Oct. 7, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription...
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks
PARSIPPANY, N.J., July 25, 2011 /PRNewswire/ – Daiichi Sankyo, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol...
FDA Approves Updates to Lilly's Humalog (insulin lispro injection [rDNA origin]) Label
Update for Insulin Pump Use Provides an Additional Option for Children With Type 1 Diabetes and Extends Amount of Time People Can Use and Store Humalog Insulin in Their Pumps INDIANAPOLIS, June 8,...
FDA Approves Tradjenta for Type 2 Diabetes
SILVER SPRING, Md., May 2, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose...
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--Nov 5, 2010 - Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved Kombiglyze XR for the...
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
SAN DIEGO and INDIANAPOLIS, Oct. 30, 2009 /PRNewswire-FirstCall/ – Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Medwatch Alert: Blood Glucose Meters and Test Strips
[Posted 03/11/2008] FDA reminded glucose meter users to only use strips recommended for their specific brand of meter and to read the instructions for use carefully. It is important for users to...
FDA Medwatch Alert: Bayer Diabetes Care Contour Test Strips (TS)
[Posted 12/26/2007] Bayer Diabetes Care notified healthcare professionals and consumers of a voluntary market recall of test strips (sensors) used exclusively with the Contour TS Blood Glucose Meter....
FDA Medwatch Alert: Avandia (rosiglitazone maleate) - Feb 20, 2007
Indication: Treatment of type 2 diabetes mellitus [Posted 02/20/2007] Glaxo SmithKline (GSK) notified healthcare professionals of the results of a randomized, double-blind parallel group study...
FDA Medwatch Alert: Avandaryl (rosiglitazone maleate and glimepiride)
Indication: Treatment of type 2 diabetes mellitus [Posted 02/20/2007] Glaxo SmithKline (GSK) notified healthcare professionals of the results of a randomized, double-blind parallel group study...
FDA Medwatch Alert: Avandamet (rosiglitazone maleate and metformin hydrochloride)
Indication: Treatment of type 2 diabetes mellitus [Posted 02/20/2007] Glaxo SmithKline (GSK) notified healthcare professionals of the results of a randomized, double-blind parallel group study...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Lantus Solostar, Humalog, Farxiga, Novolog, Jardiance, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, liraglutide, Invokana, Glucophage, Humulin N, insulin degludec